Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 279 participants.

Also called NCT04511234

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 279 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04511234
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Singapore, Taiwan, Thailand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04511234. Randomized; quadruple masking; primary purpose treatment. Start 2020-09-08 (actual); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
Acronym
FUTURE-SFA
Condition
Peripheral Artery Disease
Condition
Atherosclerosis
Condition
Arterial Disease
Intervention (Device)
MagicTouch PTA sirolimus drug coated balloon (DCB)
Intervention (Device)
POBA standard balloon
Lead sponsor
Concept Medical Inc. (class: industry)

Record details

Record id
cardio:ct-nct04511234
Content hash
93e758d7a52d8b0995438e151956fc167191b1eaa8ea2a45bdde55f5969b7e94